US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
DS

DSFIR.AS

$90.88
Sharia status
COMPLIANT
Per In-house ratio engine · assessed 2026-08-27
HTR non-permissible income 0.66%
🕌Open research, not a fatwa — verify with your own scholar.
Trade setup SEPARATE FROM SHARIAH
No active setup right now. The technical picture doesn't show a clear edge — check back when the trend or momentum shifts.

DSM-Firmenich AG (DSFIR.AS) is currently considered halal (Sharia-compliant), per In-house ratio engine (last assessed 2026-08-27). See the full ratio breakdown and business-activity screen below for the reasoning.

Market & analysts
Price target
$93.62
+3.0% · 20 analysts
Institutional own.
46.5%
of shares
COMPLIANT
Sharia compliance
0.66%
Non-permissible income — HTR, from filings (2025-12-31)
$93.62
Price target (+3.0%) · 20 analysts
46.5%
Institutional ownership

🕌 In-house Compliance Research

Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2025-12-31. DSFIR.AS files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.

Business activity: cleared (no excluded categories detected)

AAOIFI Pass

RatioValueThresholdResult
Interest-bearing debt 25.18% 30.00% Pass
Interest-bearing investments 8.35% 30.00% Pass
Non-permissible income 0.66% 5.00% Pass

Usmani Pass

RatioValueThresholdResult
Interest-bearing debt 19.56% 33.00% Pass
Interest-bearing investments 6.48% 33.00% Pass
Non-liquid assets 87.24% at least 20.00% Pass
Non-permissible income 0.66% 5.00% Pass

MSCI Pass

RatioValueThresholdResult
Interest-bearing debt 19.56% 33.33% Pass
Cash + interest-bearing securities 6.48% 33.33% Pass
Accounts receivable 12.76% 33.33% Pass
Non-permissible income 0.66% 5.00% Pass

FTSE Pass

RatioValueThresholdResult
Interest-bearing debt 19.56% 33.33% Pass
Cash + interest-bearing securities 6.48% 33.33% Pass
Accounts receivable 12.76% 50.00% Pass
Non-permissible income 0.66% 5.00% Pass

Dow Jones Islamic Market Pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 28.12% 33.00% Pass
Cash + interest-bearing securities 9.32% 33.00% Pass
Accounts receivable 9.02% 33.00% Pass
Non-permissible income 0.66% 5.00% Pass

S&P Shariah Pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 27.92% 33.00% Pass
Cash + interest-bearing securities 9.26% 49.00% Pass
Accounts receivable 8.96% 49.00% Pass
Non-permissible income 0.66% 5.00% Pass

MSCI M-Series Pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 27.92% 33.33% Pass
Cash + interest-bearing securities 9.26% 33.33% Pass
Accounts receivable 18.21% 49.00% Pass
Non-permissible income 0.66% 5.00% Pass

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

95.7485.1474.5463.9453.352025-09-112026-03-122026-09-11

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
87.05
S2
88.27
S1
89.13
PIVOT
90.35
R1
91.21
R2
92.43
R3
93.29

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

7-day expected range
88.5592 98.9608
±5.55% from 93.76, made 2026-09-03 · resolves 2026-09-10
STRONG BUY
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 21977 forecast(s) are currently open and will be scored automatically when their horizon expires.

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

Technical Summary

SELL
19 indicators
OscillatorsSELL
2 buy · 2 neutral · 3 sell
Moving averagesNEUTRAL
6 buy · 0 neutral · 6 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)48.60NEUTRAL
Stochastic %K (14)19.73BUY
CCI (20)-44.29NEUTRAL
Williams %R (14)-80.27BUY
MACD (12,26,9)-0.63SELL
ROC (10)-2.93SELL
Momentum (10)-2.74SELL
EMA (10)92.14SELL
SMA (10)93.27SELL
EMA (20)91.88SELL
SMA (20)91.83SELL
EMA (30)90.91SELL
SMA (30)92.20SELL
EMA (50)88.23BUY
SMA (50)89.13BUY
EMA (100)82.11BUY
SMA (100)79.78BUY
EMA (200)75.74BUY
SMA (200)70.90BUY

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

About DSM-Firmenich AG

Basic Materials · Specialty Chemicals

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through Perfumery & Beauty; Taste, Texture & Health; and Health, Nutrition & Care segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. DSM-Firmenich AG was founded in 1902 and is based in Kaiseraugst, Switzerland.

dsm-firmenich.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

🕌 In-house Ratio Research — filings.xbrl.org ESEF XBRL

Research only, not the primary verdict above — SEC EDGAR (the source for the main in-house research card, if shown) has no data for this symbol, so this is computed from a real, country-specific filing instead. Business-activity screening isn't part of this check.

AAOIFI Standard 21 (% of market cap) — Unverified
Debt ratio 19.9% (< 30%)
Investments ratio 11.9% (< 30%)
Non permissible income ratio no data
Usmani (% of total assets) — Unverified
Debt ratio 13.2% (< 33%)
Investments ratio 7.9% (< 33%)
Nonliquid assets ratio 92.1% (< 20%)
Non permissible income ratio no data
Net liquid assets -$1.7B (mkt cap $22.3B)

Based on the filing period ending 2024-12-31, figures in EUR.

SMC — Top Down

Not enough price history yet for a smart-money structure read on any timeframe.

Momentum & Volume

Peer Movement

Peer movement computing — it will appear here on its own.

Insider Activity (90d)

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

NEUTRAL   report date 2026-09-01 · Asset managers net 934180 (-19048)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.